Does VEDOLIZUMAB Cause White blood cell count increased? 200 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 200 reports of White blood cell count increased have been filed in association with VEDOLIZUMAB (ENTYVIO). This represents 0.3% of all adverse event reports for VEDOLIZUMAB.
200
Reports of White blood cell count increased with VEDOLIZUMAB
0.3%
of all VEDOLIZUMAB reports
37
Deaths
132
Hospitalizations
How Dangerous Is White blood cell count increased From VEDOLIZUMAB?
Of the 200 reports, 37 (18.5%) resulted in death, 132 (66.0%) required hospitalization, and 41 (20.5%) were considered life-threatening.
Is White blood cell count increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VEDOLIZUMAB. However, 200 reports have been filed with the FAERS database.
What Other Side Effects Does VEDOLIZUMAB Cause?
Off label use (21,017)
Colitis ulcerative (13,455)
Crohn's disease (9,759)
Drug ineffective (8,424)
Diarrhoea (7,493)
Abdominal pain (6,401)
Fatigue (5,477)
Haematochezia (5,215)
Frequent bowel movements (4,527)
Arthralgia (4,028)
What Other Drugs Cause White blood cell count increased?
CLOZAPINE (2,988)
ADALIMUMAB (1,710)
RUXOLITINIB (1,529)
IBRUTINIB (1,390)
RITUXIMAB (886)
METHOTREXATE (741)
PREDNISONE (716)
ETANERCEPT (615)
IMATINIB (520)
TOCILIZUMAB (478)
Which VEDOLIZUMAB Alternatives Have Lower White blood cell count increased Risk?
VEDOLIZUMAB vs VELAGLUCERASE ALFA
VEDOLIZUMAB vs VELCADE
VEDOLIZUMAB vs VELETRI
VEDOLIZUMAB vs VELIPARIB
VEDOLIZUMAB vs VEMURAFENIB